MedTrace Logo

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA

NCT02159794 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-03-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at High Risk for aortic valve replacement surgery.

Conditions

  • Severe Aortic Stenosis

Interventions

DEVICE

HLT Transcatheter Aortic Valve System

Transcatheter aortic valve replacement with an HLT Transcatheter Aortic Valve System

Sponsors & Collaborators

  • HLT Inc.

    lead INDUSTRY

Principal Investigators

  • Josep Rodés-Cabau, M.D. · Quebec Heart and Lung Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-12-31
Completion
2020-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02159794 on ClinicalTrials.gov